$15.93 MKT CAP....over $1,291 trailing 12 month revenue.
12 times sales for a company now growing revenue at 40% YOY and near 20% QoQ now its escaping the COVID era.
Bought a little more myself, despite the dreaded capital raise or debt borrow looming unless it pulls some additional partnerships out of the bag. Hence its so cheap of course. A decent 2 to 3 year investment return I suspect, from these low buy-ins, if revenues continue to grow as such, but little solace for long term investors like yourself
@Eqz.
